OPENPediatrics

Evidence for Everyone: Studying Antibiotic Use for Pneumonia in Children With Medical Complexity‌

Feb 17, 2026
Jeffery Gerber, pediatric infectious disease and stewardship expert, and Kathleen Chiotos, researcher focused on pediatric infectious diseases and stewardship, discuss antibiotic use in children with medical complexity. They explore why these children are often excluded from guidelines. They cover study design choices, time-series methods, findings on antibiotic choice and duration, and recommendations for more inclusive future research.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
INSIGHT

Feedback Reports Change Group Behavior Beyond Targets

  • Clinician feedback reports act as a group-level behavior change tool that can influence care beyond the patients included in the reports.
  • Although children with medical complexity (CMC) were excluded from reports, the same clinicians changed prescribing across their entire patient panel, creating an off-target effect.
INSIGHT

No Clear Harm Signal Applying Stewardship To CMC

  • Post hoc time-series analysis showed an increase in appropriate antibiotic choice for CMC after the intervention and a non-significant increase in appropriate duration.
  • The authors interpret these as hypothesis-generating results suggesting no clear signal of harm from applying stewardship metrics to many CMC.
ADVICE

Define CMC Subgroups For Clearer Study Results

  • Include more narrowly defined CMC subgroups in future studies instead of the broad CCC scheme to get actionable conclusions.
  • For example, focus on children with neurologic impairment to study aspiration concerns and device-related risks separately.
Get the Snipd Podcast app to discover more snips from this episode
Get the app